Vor Biopharma Inc. (18)

Browse by Contract Category

Contracts

Executive Severance and Change in Control Benefits Plan (Filed With SEC on February 1, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)
Offer Letter, by and between the Registrant and Tirtha Chakraboty, dated August 28, 2019 (Filed With SEC on January 15, 2021)
Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York, dated April 28, 2016 (Filed With SEC on January 15, 2021)
Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on January 15, 2021)
Lease Agreement, by and between the Registrant and PPF Off 100 Cambridge Park Drive, LLC, dated December 17, 2019 (Filed With SEC on January 15, 2021)
Non-Employee Director Compensation Policy (Filed With SEC on February 1, 2021)
2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement (Filed With SEC on February 1, 2021)
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 30, 2020 (Filed With SEC on February 1, 2021)
Form of Common Stock Certificate of the Registrant (Filed With SEC on February 1, 2021)
Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
First Amendment to Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York, dated February 12, 2019 (Filed With SEC on January 15, 2021)
Offer Letter, by and between the Registrant and Christopher Slapak, dated July 2, 2020 (Filed With SEC on January 15, 2021)
Offer Letter, by and between the Registrant and Sadik Kassim, dated August 12, 2019 (Filed With SEC on January 15, 2021)
Offer Letter, by and between the Registrant and Robert Ang, dated June 28, 2019 (Filed With SEC on January 15, 2021)
2015 Stock Incentive Plan and Forms of Option Grant Agreements, Exercise Notices and Restricted Stock Agreement (Filed With SEC on January 15, 2021)
Patent License Agreement, by and between the Registrant and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, dated October 30,... (Filed With SEC on January 15, 2021)
Offer Letter, by and between the Registrant and Nathan Jorgensen, dated March 20, 2020 (Filed With SEC on January 15, 2021)